Author

Emma K. Emanuelsson

Observed names: E.K. Emanuelsson, Emma Emanuelsson

Institution: Karolinska Institutet

Observed institutions: Karolinska University Hospital, Karolinska Institutet

OpenAlex ID: A5025978436

Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q− syndrome patients

2007 · Andrea Pellagatti, Martin Jädersten, et al. · Proceedings of the National Academy of Sciences · 233

Mantle cell lymphomas with low levels of cyclin D1 long mRNA transcripts are highly proliferative and can be discriminated by elevated cyclin A2 and cyclin B1

2005 · Birgitta Sander, Jenny Flygare, et al. · International Journal of Cancer · 40

Antiapoptotic Role of Growth Factors in the Myelodysplastic Syndromes: Concordance Between In vitro and In vivo Observations

2005 · Ramin Tehranchi, Bengt Fadeel, et al. · Clinical Cancer Research · 38

Lenalidomide Selectively Inhibits In Vitro Growth of the Malignant Clone in Myelodysplastic Syndrome (MDS) Patients with 5q Deletion.

2005 · Martin Jädersten, Andrea Pellagatti, et al. · Blood · 5

O-17 Thalidomide analogue CC5013 (revlimid) selectively inhibits in vitro growth of the malignant clone in myelodysplastic syndrome (MDS) patients with 5Q deletion

2005 · M. Jadersten, A.-M. Forsblom, et al. · Leukemia Research · 2

Lenalidomide Up-Regulates SPARC and Inhibits In Vitro Growth of the Malignant Clone in Myelodysplastic Syndrome Patients with 5q Deletion.

2006 · Andrea Pellagatti, Martin Jädersten, et al. · Blood · 1

Works count: 6

Citation count: 319

H-index: 4

I10-index: 3